Aripiprazole-induced agitation after clozapine discontinuation: a case report.
Cho
Dara Y
DY
Lindenmayer
Jean-Pierre
JP
D017109:Akathisia, Drug-Induced / Q000175:diagnosis / Q000209:etiology*; D000437:Alcoholism / Q000453:epidemiology; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000068180:Aripiprazole; D003024:Clozapine / Q000009:adverse effects*; D019970:Cocaine-Related Disorders / Q000453:epidemiology; D015897:Comorbidity; D003692:Delayed-Action Preparations; D016883:Diabetic Ketoacidosis / Q000139:chemically induced; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008875:Middle Aged; D008972:Molindone / Q000627:therapeutic use; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D015363:Quinolones / Q000008:administration & dosage / Q000009:adverse effects*; D012563:Schizophrenia, Paranoid / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole; D003024:Clozapine; D008972:Molindone